Preclinical antitumor efficacy of analogs of XK469: sodium-(2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionate
Corbett T, LoRusso P, Demchick L, Simpson C, Pugh S, White K, Kushner J, Polin L, Meyer J, Czarnecki J, Heilbrun L, Horwitz J, Gross J, Behrens C, Harrison B, McRipley R, Trainor G. Preclinical antitumor efficacy of analogs of XK469: sodium-(2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionate. Investigational New Drugs 1998, 16: 129-139. PMID: 9848576, DOI: 10.1023/a:1006174622061.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsAntineoplastic AgentsDrug Screening Assays, AntitumorFemaleMaleMiceMolecular StructureQuinoxalines